ResMed Financial Statements From 2010 to 2024

RMD Stock  USD 177.61  3.78  2.17%   
ResMed financial statements provide useful quarterly and yearly information to potential ResMed Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ResMed financial statements helps investors assess ResMed's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ResMed's valuation are summarized below:
Gross Profit
2.4 B
Profit Margin
0.1977
Market Capitalization
27.2 B
Enterprise Value Revenue
6.3318
Revenue
4.5 B
There are over one hundred nineteen available trending fundamental ratios for ResMed Inc, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of ResMed's recent performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 461.4 M. The current year's Enterprise Value is expected to grow to about 451 M

ResMed Total Revenue

5.1 Billion

Check ResMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ResMed main balance sheet or income statement drivers, such as Depreciation And Amortization of 238.6 M, Total Revenue of 5.1 B or Gross Profit of 2.8 B, as well as many exotic indicators such as Price To Sales Ratio of 4.25, Dividend Yield of 0.0183 or PTB Ratio of 4.78. ResMed financial statements analysis is a perfect complement when working with ResMed Valuation or Volatility modules.
  
This module can also supplement ResMed's financial leverage analysis and stock options assessment as well as various ResMed Technical models . Check out the analysis of ResMed Correlation against competitors.

ResMed Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.2 B7.8 BB
Slightly volatile
Short and Long Term Debt Total1.9 B1.8 B885 M
Slightly volatile
Other Current Liabilities528.7 M503.6 M278.3 M
Slightly volatile
Total Current Liabilities915.9 M872.3 M545.5 M
Slightly volatile
Total Stockholder EquityB4.7 B2.5 B
Slightly volatile
Property Plant And Equipment Net804 M765.7 M481 M
Slightly volatile
Retained Earnings5.1 B4.9 B2.7 B
Slightly volatile
Accounts Payable182 M173.4 M107.7 M
Slightly volatile
Cash335.8 M262.1 M470.5 M
Slightly volatile
Non Current Assets Total5.3 BB2.4 B
Slightly volatile
Non Currrent Assets Other477.5 M454.7 M191.2 M
Slightly volatile
Cash And Short Term Investments340.4 M262.1 M470.8 M
Slightly volatile
Net Receivables851.2 M810.6 M480.3 M
Slightly volatile
Common Stock Shares Outstanding147.3 M169.6 M140.5 M
Slightly volatile
Liabilities And Stockholders Equity8.2 B7.8 BB
Slightly volatile
Non Current Liabilities Total2.2 B2.1 B982.2 M
Slightly volatile
Inventory1.2 B1.1 B454.2 M
Slightly volatile
Other Current Assets527.7 M502.6 M202.4 M
Slightly volatile
Total Liabilities3.2 BB1.5 B
Slightly volatile
Total Current Assets2.9 B2.7 B1.6 B
Slightly volatile
Short Term Debt66.7 M36.6 M81.5 M
Pretty Stable
Intangible Assets667 M635.2 M302.5 M
Slightly volatile
Property Plant And Equipment Gross804 M765.7 M481.2 M
Slightly volatile
Common Stock Total Equity417 K670.5 K536.9 K
Slightly volatile
Common Stock435.6 K676.2 K539.4 K
Slightly volatile
Other Assets315.5 M300.5 M144.8 M
Slightly volatile
Good Will3.3 B3.2 B1.4 B
Slightly volatile
Property Plant Equipment384.1 M765.7 M455.4 M
Slightly volatile
Other Liabilities380.6 M362.5 M150.9 M
Slightly volatile
Long Term Debt1.7 B1.6 B790.9 M
Slightly volatile
Current Deferred Revenue166.7 M158.8 M80.2 M
Slightly volatile
Retained Earnings Total Equity2.3 B3.3 B2.3 B
Slightly volatile
Long Term Debt Total737.7 M880.1 M646.1 M
Slightly volatile
Capital Surpluse1.5 B1.9 B1.4 B
Slightly volatile
Non Current Liabilities Other45 M78.4 M38.5 M
Slightly volatile
Deferred Long Term Asset Charges42.6 M52.3 M38.2 M
Slightly volatile
Short and Long Term Debt8.5 M8.9 M197.8 M
Slightly volatile
Long Term Investments42 M59.9 M40.3 M
Slightly volatile
Net Invested CapitalB6.4 B3.6 B
Slightly volatile
Cash And Equivalents254.8 M246.3 M397.2 M
Slightly volatile
Net Working Capital1.1 B1.9 B1.2 B
Very volatile
Capital Stock640.6 K676.2 K588.6 K
Slightly volatile
Capital Lease Obligations149.2 M159.6 M130.6 M
Slightly volatile

ResMed Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization238.6 M227.2 M129.1 M
Slightly volatile
Total Revenue5.1 B4.9 B2.6 B
Slightly volatile
Gross Profit2.8 B2.7 B1.5 B
Slightly volatile
Other Operating Expenses3.7 B3.5 B1.9 B
Slightly volatile
Operating Income1.4 B1.3 B663.6 M
Slightly volatile
EBIT1.4 B1.3 B675.8 M
Slightly volatile
EBITDA1.6 B1.5 B804.9 M
Slightly volatile
Cost Of Revenue2.3 B2.1 B1.1 B
Slightly volatile
Total Operating Expenses1.5 B1.4 B817.6 M
Slightly volatile
Income Before Tax1.3 B1.3 B650.7 M
Slightly volatile
Net Income1.1 BB504.3 M
Slightly volatile
Income Tax Expense246.5 M234.7 M146.3 M
Slightly volatile
Selling General Administrative1.1 BB605.4 M
Slightly volatile
Research Development347.3 M330.8 M180.7 M
Slightly volatile
Net Income Applicable To Common Shares1.1 BB526.2 M
Slightly volatile
Selling And Marketing Expenses4.3 M6.3 M5.4 M
Very volatile
Net Income From Continuing Ops1.1 BB519.4 M
Slightly volatile
Tax Provision180 M234.7 M147.9 M
Slightly volatile
Interest Income31.4 M51.4 M29.4 M
Slightly volatile
Reconciled Depreciation180.3 M227.2 M148.5 M
Slightly volatile

ResMed Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow675.4 M643.2 M420.2 M
Slightly volatile
Begin Period Cash Flow327.7 M314.8 M507.2 M
Slightly volatile
Depreciation238.6 M227.2 M134 M
Slightly volatile
Capital Expenditures161.8 M154.1 M93.5 M
Slightly volatile
Total Cash From Operating Activities837.2 M797.3 M513.7 M
Slightly volatile
Net Income1.1 BB504.3 M
Slightly volatile
End Period Cash Flow336.6 M262.1 M470.5 M
Slightly volatile
Stock Based Compensation85.9 M81.8 M51.9 M
Slightly volatile
Dividends Paid195.3 M297 M192 M
Slightly volatile
Issuance Of Capital Stock48.2 M56.5 M41.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.256.836.1418
Slightly volatile
Dividend Yield0.01830.00930.0159
Slightly volatile
PTB Ratio4.786.997.0477
Slightly volatile
Days Sales Outstanding59.7854.8370.3375
Slightly volatile
Book Value Per Share26.5925.3316.0769
Slightly volatile
Free Cash Flow Yield0.01740.01570.0308
Slightly volatile
Invested Capital0.240.340.3356
Pretty Stable
Operating Cash Flow Per Share4.464.253.4004
Slightly volatile
Stock Based Compensation To Revenue0.0260.01940.0227
Slightly volatile
PB Ratio4.786.997.0477
Slightly volatile
EV To Sales4.27.126.169
Slightly volatile
Free Cash Flow Per Share3.63.432.7842
Slightly volatile
ROIC0.0960.150.1432
Very volatile
Inventory Turnover2.141.682.8789
Slightly volatile
Net Income Per Share5.785.53.2761
Slightly volatile
Days Of Inventory On Hand162224134
Slightly volatile
Payables Turnover5.7711.158.8916
Slightly volatile
Sales General And Administrative To Revenue0.340.30.2791
Pretty Stable
Research And Ddevelopement To Revenue0.07920.07830.0727
Pretty Stable
Cash Per Share1.731.473.241
Slightly volatile
POCF Ratio24.3541.6332.813
Slightly volatile
Payout Ratio0.510.330.4573
Pretty Stable
PFCF Ratio42.2365.9445.2788
Slightly volatile
Days Payables Outstanding61.4833.8944.7848
Slightly volatile
Income Quality0.950.71.1666
Slightly volatile
ROE0.140.20.1985
Pretty Stable
EV To Operating Cash Flow25.1743.3833.1606
Slightly volatile
PE Ratio28.1432.1635.0333
Slightly volatile
Return On Tangible Assets0.130.240.1971
Slightly volatile
EV To Free Cash Flow44.5768.7245.8729
Slightly volatile
Earnings Yield0.03750.03220.033
Slightly volatile
Intangibles To Total Assets0.470.440.3496
Slightly volatile
Current Ratio4.043.593.3462
Pretty Stable
Receivables Turnover5.476.895.2538
Slightly volatile
Graham Number58.856.034.3453
Slightly volatile
Shareholders Equity Per Share26.5925.3316.0769
Slightly volatile
Debt To Equity0.240.340.3356
Pretty Stable
Revenue Per Share27.1925.916.9508
Slightly volatile
Interest Debt Per Share9.879.45.9449
Slightly volatile
Debt To Assets0.140.210.1996
Pretty Stable
Enterprise Value Over EBITDA24.1828.6927.1512
Pretty Stable
Short Term Coverage Ratios18.6319.61K
Slightly volatile
Price Earnings Ratio28.1432.1635.0333
Slightly volatile
Operating Cycle244294207
Slightly volatile
Price Book Value Ratio4.786.997.0477
Slightly volatile
Days Of Payables Outstanding61.4833.8944.7848
Slightly volatile
Dividend Payout Ratio0.510.330.4573
Pretty Stable
Price To Operating Cash Flows Ratio24.3541.6332.813
Slightly volatile
Price To Free Cash Flows Ratio42.2365.9445.2788
Slightly volatile
Pretax Profit Margin0.180.230.2344
Very volatile
Ebt Per Ebit1.131.121.066
Slightly volatile
Operating Profit Margin0.160.240.2294
Slightly volatile
Effective Tax Rate0.320.210.2448
Very volatile
Company Equity Multiplier1.221.471.5796
Very volatile
Long Term Debt To Capitalization0.140.250.2073
Slightly volatile
Total Debt To Capitalization0.160.250.2346
Pretty Stable
Return On Capital Employed0.140.170.1889
Pretty Stable
Debt Equity Ratio0.240.340.3356
Pretty Stable
Ebit Per Revenue0.160.240.2294
Slightly volatile
Quick Ratio2.641.432.2502
Slightly volatile
Net Income Per E B T0.570.730.7439
Pretty Stable
Cash Ratio0.260.271.2032
Slightly volatile
Cash Conversion Cycle133204155
Slightly volatile
Operating Cash Flow Sales Ratio0.150.16420.2073
Slightly volatile
Days Of Inventory Outstanding162224134
Slightly volatile
Days Of Sales Outstanding59.7854.8370.3375
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.760.730.7948
Pretty Stable
Cash Flow Coverage Ratios0.480.50.9763
Slightly volatile
Price To Book Ratio4.786.997.0477
Slightly volatile
Fixed Asset Turnover5.877.295.9365
Very volatile
Price Cash Flow Ratio24.3541.6332.813
Slightly volatile
Enterprise Value Multiple24.1828.6927.1512
Pretty Stable
Debt Ratio0.140.210.1996
Pretty Stable
Cash Flow To Debt Ratio0.480.50.9763
Slightly volatile
Price Sales Ratio4.256.836.1418
Slightly volatile
Return On Assets0.130.150.1287
Very volatile
Asset Turnover0.80.720.7307
Slightly volatile
Net Profit Margin0.130.190.1788
Very volatile
Gross Profit Margin0.670.640.6004
Very volatile
Price Fair Value4.786.997.0477
Slightly volatile
Return On Equity0.140.20.1985
Pretty Stable

ResMed Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap461.4 M439.5 M453.1 M
Slightly volatile
Enterprise Value451 M429.5 M442.6 M
Slightly volatile

ResMed Fundamental Market Drivers

Forward Price Earnings23.31
Cash And Short Term Investments227.9 M

ResMed Upcoming Events

25th of April 2024
Upcoming Quarterly Report
View
1st of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
1st of August 2024
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About ResMed Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include ResMed income statement, its balance sheet, and the statement of cash flows. ResMed investors use historical funamental indicators, such as ResMed's revenue or net income, to determine how well the company is positioned to perform in the future. Although ResMed investors may use each financial statement separately, they are all related. The changes in ResMed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ResMed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ResMed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ResMed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue158.8 M166.7 M
Total Revenue4.9 B5.1 B
Cost Of Revenue2.1 B2.3 B
Stock Based Compensation To Revenue 0.02  0.03 
Sales General And Administrative To Revenue 0.30  0.34 
Research And Ddevelopement To Revenue 0.08  0.08 
Capex To Revenue(0.03)(0.03)
Revenue Per Share 25.90  27.19 
Ebit Per Revenue 0.24  0.16 

ResMed Investors Sentiment

The influence of ResMed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ResMed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ResMed's public news can be used to forecast risks associated with an investment in ResMed. The trend in average sentiment can be used to explain how an investor holding ResMed can time the market purely based on public headlines and social activities around ResMed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ResMed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ResMed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ResMed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on ResMed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ResMed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ResMed's short interest history, or implied volatility extrapolated from ResMed options trading.

Currently Active Assets on Macroaxis

When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Check out the analysis of ResMed Correlation against competitors.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for ResMed Stock analysis

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
1.84
Earnings Share
6.04
Revenue Per Share
30.633
Quarterly Revenue Growth
0.125
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.